Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 07'th Jan 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Fresenius (FMS) is a Strong Momentum Stock
10:51am, Thursday, 18'th Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
08:15am, Thursday, 11'th Dec 2025
FMS's acquisitions, partnerships and global reach fuel growth, even as rising costs and optimization efforts weigh on near-term performance.
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board
08:00am, Wednesday, 10'th Dec 2025
Effective January 1, 2026, Charles Hugh-Jones will join the Management Board as Global Chief Medical Officer As part of a planned transition Franklin W. Maddux will retire by year end BAD HOMBURG, Ger
Here's Why Fresenius (FMS) is a Strong Value Stock
10:40am, Wednesday, 26'th Nov 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Fresenius Medical Care: 'Buy' Again Following A Peak In May
10:50am, Tuesday, 25'th Nov 2025
Fresenius Medical Care (FMS) is rated a 'Buy,' citing strong fundamentals. FMS demonstrates robust revenue growth, margin expansion, and dividend safety, with a new HVHDF product rollout expected to d
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
10:41am, Monday, 10'th Nov 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
FMS Stock Rises as Q3 Earnings Beat Estimates, Revenues Gain Y/Y
11:56am, Wednesday, 05'th Nov 2025
Fresenius Medical Care's Q3 earnings and revenues beat estimates, fueled by margin gains and solid organic growth across segments.
Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript
04:26pm, Tuesday, 04'th Nov 2025
Fresenius Medical Care AG ( FMS ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Dominik Heger - Executive VP and Head of Investor Relations, Strategic Development & Communica
Strong organic revenue growth1 of 10% driven by all operating segments Positive U.S. same market treatment growth of 0.1 % in line with expectations Accelerated operating income2 growth of 28% at cons
Fresenius Medical Care beats quarterly profit estimates helped by cost cuts
01:08am, Tuesday, 04'th Nov 2025
Fresenius Medical Care reported a third-quarter operating income that exceeded analysts' expectations on Tuesday, in a sign that the dialysis specialist's cost-cutting measures were beginning to take
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Given Average Recommendation of “Hold” by Analysts
04:00am, Monday, 03'rd Nov 2025
Shares of Fresenius Medical Care AG and Co. KGaA (NYSE: FMS - Get Free Report) have received a consensus recommendation of "Hold" from the seven research firms that are presently covering the company,
Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025
09:00am, Thursday, 30'th Oct 2025
Fresenius Medical Care researchers will present multiple abstracts that demonstrate proven, real-world benefits of hemodiafiltration (HDF), with one accepted as an oral presentation. Oral presentation
CVS vs. FMS: Which Healthcare Services Stock Has More Upside?
09:46am, Monday, 27'th Oct 2025
CVS outpaces FMS in share gains and valuation appeal, with stronger earnings momentum and expanding health services driving its edge.
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
02:51pm, Friday, 24'th Oct 2025
FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.
